ArticleTranslational cancer research2025
Machine learning and deep learning to improve overall survival prediction in cervical cancer patients.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep learning assisting the surgical management of gynecologic cancers.Current opinion in oncology · 2026Review
- Leveraging AI solutions for sustainable practice in pediatric radiology: a practical guide and an educational tool.Pediatric radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer (CC) is one of the most common gynecological malignancies. Previous studies have shown that the prognosis of CC is affected by many factors. Our study aimed to identify key prognostic factors and use machine learning and deep learning algorithms to construct models to predict the overall survival (OS) of CC patients. Methods: Data of CC patients collected between 2007 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database, and were randomly divided into the training set (1,743 patients) and test set (747 patients). Moreover, in order to enhance the practical application of the model, we conducted an X-tile analysis to categorize the patients into three distinct strata based on their age and tumor size. Least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression were performed to identify the independent prognostic factors for OS, which were further used to construct CoxBoost, RandomForest, SuperPC XGBoost, and DeepSurv survival models to predict 1-, 3-, and 5-year OS. Results: The parameters, including age, marital status, grade, tumor size, surgery, radiation, race, the American Joint Committee on Cancer (AJCC)_stage, AJCC_T, and AJCC_M, were associated with survival and were further incorporated into the five models. The concordance index (C-index) value was 0.858, 0.848, 0.849, 0.840, and 0.869, respectively, and the receiver operating characteristic (ROC) curves showed exceptional predictive performance. Among the five models, DeepSurv was the model with best performance. The ROC curve validated the area under the curve (AUC) values for 1-year OS, 3-year OS, and 5-year OS, which were 0.936, 0.915, and 0.900, respectively. Conclusions: The prognostic model conducted by DeepSurv algorithm and the independent prognostic factors can potentially be applied in making personalized treatment plans and evaluating the prognosis of CC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.